Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial-Reference-Cited by-同舟云学术

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial

Published:2022-04-21 Issue:5 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Knuf Markus¹,Rämet Mika²,Breinholt Stærke Nina³,Bertrand-Gerentes Isabelle⁴,Thollot Yaël⁴,B'Chir Siham⁵,Arroum Habiba⁶,Oster Philipp⁴

Affiliation:

1. Helios Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany

2. Vaccine Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland

3. Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

4. Global Medical Operations, Sanofi, Lyon, France

5. Global Biostatistical Sciences, Sanofi, Marcy-l’Étoile, France

6. Global Pharmacovigilance, Sanofi, Chilly-Mazarin, France

Funder

Sanofi Pasteur

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2052657

Reference27 articles.

1. European Centre for Disease Prevention and Control. Disease data from ECDC surveillance Atlas for meningococcal disease. European Centre for Disease Prevention and Control. 2018. https://www.ecdc.europa.eu/en/meningococcal-disease/surveillance-and-disease-data/atlas

2. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination

3. European Centre for Disease Prevention and Control. Factsheet about meningococcal disease. 2019. https://www.ecdc.europa.eu/en/meningococcal-disease/factsheet

4. Meningococcal disease epidemiology in Brazil (2005–2018) and impact of MenC vaccination

5. Australian Government-Department of Health. Invasive meningococcal disease National Surveillance Report-1 January to 30 June 2019. Invasive Meningococcal Disease National Surveillance Report: Australian Government-Department of Health; 2019. https://www1.health.gov.au/internet/main/publishing.nsf/Content/5FEABC4B495BDEC1CA25807D001327FA/$File/IMD-surveil-report-Jan-June-2019.pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study;Infectious Diseases and Therapy;2024-07-02

2. Meningokokkenimpfung;Monatsschrift Kinderheilkunde;2024-04-08

3. Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older;Infectious Diseases and Therapy;2023-09-27

4. Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT): A review of the evidence and expert opinion;Expert Review of Vaccines;2023-05-15

5. Efficacy and Safety of Quadrivalent Conjugate Meningococcal Vaccines: A Systematic Review and Meta-Analysis;Vaccines;2023-01-13